Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
NCT06485609 · NA · Guangzhou, China
- Condition
- Colorectal Cancer
- Disease stage
- Stage I-IV
- Phase
- NA
- Study type
- PROCEDURE
- Intervention
- radical right hemicolectomy combined with indocyanine green fluorescence imaging lymphatic tracer dissection
- Age
- 18 Years to 75 Years
- Gender
- All
- Sponsor
- Sun Yat-sen University
- Research institution
- Sun Yat-sen University
- Facility
- The Sixth Affiliated Hospital, Sun Yat-sen University
- Research center
- The Sixth Affiliated Hospital, Sun Yat-sen University
Summary
The purpose of this study is to explore the clinical outcomes of indocyanine green fluorescence using in laparoscopic radical right hemicolectomy for right colon cancer（T1-T4a N+ M0）
Inclusion criteria
* 1\. Age between 18 and 75 years old 2. Confirmed adenocarcinoma cancer pathologically 3. Location of tumor: from the cecum to the right third of the transverse colon 4. CT showed right colon cancer: T1-T4a N+ M0 5. ASA scores I-III 6. ECOG (Eastern Cooperative Oncology Group) scale performance status of 0 or 1 7. Patient or family member, able to understand the study protocol and willing to participate in the study, providing written informed consent
Exclusion criteria
* 1\. Simultaneous or heterochronic multiple primary colon cancer 2. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. requiring emergency surgery 3. Unsuitable for laparoscopic surgery (e.g., extensive adhesions due to previous major abdominal surgery; unsuitable for pneumoperitoneum for various reasons, etc.) 4. Pregnant or lactating women 5. Have a history of serious mental illness 6. History of iodine allergy 7. History of other malignant diseases within the last five years 8. History of prior neoadjuvant chemotherapy or radiation therapy 9. History of unstable angina or myocardial infarction within the last 6 months 10. History of continuous systemic corticosteroid use within one month
Primary outcomes
Disease-free survival rate
Secondary outcomes
Number of lymph nodes cleared